Competition authority interferes with Takeda's deal with Danish Orifarm
Following 'thorough investigations' the Danish Competition and Consumer Authority has approved that Orifarm can take over a range of drugs and factories from Japanese Takeda. However, in return, the firm has to divest several products and rights.
BY IBEN SCHMIDT, TRANSLATED BY NIELSINE NIELSEN
The Danish Competition and Consumer Authority could not approve the whole of Danish supplier company Orifarm's billion-kroner deal with Japanese medical company from last year.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
.jpg&w=384&q=75)
